Simplify Asset Management Inc. Cuts Stock Holdings in agilon health, inc. (NYSE:AGL)

Simplify Asset Management Inc. lowered its holdings in agilon health, inc. (NYSE:AGL) by 34.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 110,520 shares of the company’s stock after selling 58,176 shares during the quarter. Simplify Asset Management Inc.’s holdings in agilon health were worth $210,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the business. Citigroup Inc. raised its stake in agilon health by 2,251.5% in the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after buying an additional 1,941,993 shares in the last quarter. Charles Schwab Investment Management Inc. increased its holdings in shares of agilon health by 49.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company’s stock valued at $8,629,000 after acquiring an additional 1,498,524 shares during the period. JPMorgan Chase & Co. raised its position in shares of agilon health by 326.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock worth $5,563,000 after acquiring an additional 1,083,492 shares in the last quarter. Alberta Investment Management Corp purchased a new stake in shares of agilon health during the 4th quarter worth $1,564,000. Finally, Quantbot Technologies LP bought a new stake in agilon health during the third quarter valued at about $1,742,000.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. Needham & Company LLC reissued a “hold” rating on shares of agilon health in a research report on Friday. Macquarie initiated coverage on shares of agilon health in a research report on Monday, December 16th. They set a “neutral” rating and a $3.00 target price for the company. Royal Bank of Canada lifted their price target on shares of agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a report on Wednesday, February 26th. Sanford C. Bernstein increased their price objective on agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a report on Wednesday, January 15th. Finally, Citigroup upgraded agilon health from a “sell” rating to a “neutral” rating and boosted their target price for the stock from $1.75 to $2.25 in a research note on Friday, January 10th. Two investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, agilon health has a consensus rating of “Hold” and an average target price of $3.95.

agilon health Stock Performance

Shares of NYSE AGL opened at $4.51 on Friday. The company has a 50 day simple moving average of $3.51 and a two-hundred day simple moving average of $2.95. The stock has a market cap of $1.86 billion, a price-to-earnings ratio of -4.80 and a beta of 0.67. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health, inc. has a 12 month low of $1.50 and a 12 month high of $7.73.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.